(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C73H125NO18 — CID 165305873

IUPAC(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C73H125NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-26-27-28-29-31-32-34-36-38-40-42-44-46-48-50-57(78)56(74-61(79)51-49-47-45-43-41-39-37-35-33-30-24-22-20-18-16-14-12-10-8-6-4-2)55-87-71-67(85)64(82)69(59(53-76)89-71)92-73-68(86)65(83)70(60(54-77)90-73)91-72-66(84)63(81)62(80)58(52-75)88-72/h6,8,12,14,18,20,24,30,35,37,40-43,48,50,56-60,62-73,75-78,80-86H,3-5,7,9-11,13,15-17,19,21-23,25-29,31-34,36,38-39,44-47,49,51-55H2,1-2H3,(H,74,79)/b8-6-,14-12-,20-18-,30-24-,37-35-,42-40+,43-41-,50-48+
InChIKeyUWQSIRJXIMANGX-VCSJSSHRSA-N
MW1304.79 g/mol
LogP9.66
Rot. Bonds53

About (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide (PubChem CID 165305873) has the molecular formula C73H125NO18 and a molecular weight of 1304.79 g/mol. Its IUPAC name is (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide.

Molecular Properties

Compound Name(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
PubChem CID165305873
Molecular FormulaC73H125NO18
Molecular Weight1304.79 g/mol
Exact Mass1303.89
IUPAC Name(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCC
InChIInChI=1S/C73H125NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-26-27-28-29-31-32-34-36-38-40-42-44-46-48-50-57(78)56(74-61(79)51-49-47-45-43-41-39-37-35-33-30-24-22-20-18-16-14-12-10-8-6-4-2)55-87-71-67(85)64(82)69(59(53-76)89-71)92-73-68(86)65(83)70(60(54-77)90-73)91-72-66(84)63(81)62(80)58(52-75)88-72/h6,8,12,14,18,20,24,30,35,37,40-43,48,50,56-60,62-73,75-78,80-86H,3-5,7,9-11,13,15-17,19,21-23,25-29,31-34,36,38-39,44-47,49,51-55H2,1-2H3,(H,74,79)/b8-6-,14-12-,20-18-,30-24-,37-35-,42-40+,43-41-,50-48+
InChIKeyUWQSIRJXIMANGX-VCSJSSHRSA-N
XLogP9.66
TPSA307.01 Ų
H-Bond Donors12
H-Bond Acceptors18
Rotatable Bonds53
Heavy Atoms92
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001304.79
LogP ≤ 59.66
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide?
The IUPAC name of (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide (CID 165305873) is (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide.
What is the SMILES notation for (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide?
The canonical SMILES for (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(OC3OC(CO)C(O)C(O)C3O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CCCCCCCCCCCCCCCCCCCCCC.
What is the InChIKey of (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide?
The InChIKey is UWQSIRJXIMANGX-VCSJSSHRSA-N. The full InChI is InChI=1S/C73H125NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-26-27-28-29-31-32-34-36-38-40-42-44-46-48-50-57(78)56(74-61(79)51-49-47-45-43-41-39-37-35-33-30-24-22-20-18-16-14-12-10-8-6-4-2)55-87-71-67(85)64(82)69(59(53-76)89-71)92-73-68(86)65(83)70(60(54-77)90-73)91-72-66(84)63(81)62(80)58(52-75)88-72/h6,8,12,14,18,20,24,30,35,37,40-43,48,50,56-60,62-73,75-78,80-86H,3-5,7,9-11,13,15-17,19,21-23,25-29,31-34,36,38-39,44-47,49,51-55H2,1-2H3,(H,74,79)/b8-6-,14-12-,20-18-,30-24-,37-35-,42-40+,43-41-,50-48+.
What are the key properties of (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide?
(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide has a molecular weight of 1304.79 g/mol, XLogP of 9.66, 53 rotatable bonds, 12 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhentriaconta-4,8-dien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide is sourced from PubChem (CID 165305873), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).